Drugs & medicalClass II

BioMerieux SA recalls MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO System

Under certain conditions, there is a risk for a false negative result.

Read the official notice →
Date
2021-10-20
Country
United States
Brand
Biomerieux
Product
MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO System
Classification
Class II
Units
Worldwide distribution - US Nationwide distribution and the countries of…
Category
Drugs & medical
Source
FDA · Device

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Biomerieux recalls

  1. 2022-08-31
  2. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls NUCLISENS easyMAG Magnetic Silica, REF 280133, 24 x 1.2mL bottles/kit.

    There is a potential of no result leading to possible delayed result due to contamination of extraction reagents.

    FDA · DevicebioMerieux, Inc.Distribution was made to AR, AZ, CA, CT, FL, IL, IN, KS, KY, MA, MD, MI, MN,…Official notice →
  3. 2022-05-18
  4. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls VITEK 2 Systems and VITEK 2 with MYLA.

    Software issue where results sent to the LIS via HL7 format for antibiotic screen tests and synergy tests do not include the user-corrected or AES-corrected interpretation. This can potentially lead to incorrect final…

    FDA · DevicebioMerieux, Inc.U.S. distribution of the FSCA to NC. OUS distribution of the FSCA to…Official notice →
  5. 2022-02-02
  6. US
    Drugs & medicalClass II

    Biomerieux Inc recalls API ID 32 C Strips, Reference 32200, Rx Only, IVD API ID 32 C is a qualitative standardized system for the identification of yeasts. It…

    Risk of misidentification or delayed results with the absence of identification due to thermoforming defect.

    FDA · DeviceBiomerieux IncUS (Domestic) Distribution to states of: AZ, IA, KY, and NY.Official notice →
  7. 2022-01-05
  8. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls VIDAS RUB IgG (RBG), REF 30226

    bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.

    FDA · DevicebioMerieux, Inc.US Nationwide distribution.Official notice →
  9. US
    Drugs & medicalClass II

    Biomerieux Inc recalls RAPID 20 E, REF 20701, System for the identification of Enterobacteriaceae in 4 hours, 25 strips/package, IVD.

    There is an error in the new version of the package insert. The Reading Table lists the incorrect color for a negative result for the CIT test.

    FDA · DeviceBiomerieux IncUS Nationwide distribution in the states of AL, AZ, CA, CO, CT, DE, FL, GA,…Official notice →
  10. 2021-11-24
  11. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls API 50 CH, Model 50300

    There is potential to provide an incorrect organism identification.

    FDA · DevicebioMerieux, Inc.Distribution in WI, NY, and SDOfficial notice →
All 16 Biomerieux recalls →

Other drugs & medical recalls in the United States

  1. 2021-10-20
  2. US
    Drugs & medicalClass I

    Red Medical Supplies recalls EcoGel 200 - RED Medical Supplies Blue Ultrasound Gel, Model No. 250UG-BMU

    Ultrasound gels and lotions manufactured by Eco-Med Pharmaceutical, Inc. may contain bacterial contamination. On August 18, 2021,FDA published a Letter to Health Care Providers to further address this issue:…

    FDA · DeviceRed Medical SuppliesFirm sold product through Amazon.com. Domestic distribution nationwide.Official notice →
  3. US
    Drugs & medicalClass II

    Inpeco S.A. recalls FlexLab (FLX), Accelerator a3600 (ACP), Aptio Automation (AP2). (Different brand names of same product.)

    The Firmware (FW) of the Automation System Interface Module to ADVIA Centaur XP/XPT may lead to an incorrect association of test results to sample ID. Improper management of the sample may bring an incorrect patient…

    FDA · DeviceInpeco S.A.Domestic distribution nationwide . Foreign distribution worldwide.Official notice →
  4. US
    Drugs & medicalClass II

    Medtronic Sofamor Danek USA Inc recalls Endoskeleton" TCS Interbody System with Titan nanoLOCK" Surface Technology, NanoLock, 6 Deg, Interbody, Medium, 10mm

    Engraving on implants may not match what is listed on the pouch labels.

    FDA · DeviceMedtronic Sofamor Danek USA IncDistribution in US: CA, MN, MO, NC, NV, NY, OH, OK, OR, PA, SC, SD, WA, WVOfficial notice →
  5. US
    Drugs & medicalClass II

    Roche Molecular Systems, Inc. recalls cobas EGFR Mutation Test v2-Somatic gene mutation detection system Catalog Number :07248563190

    False Mutation Detected results for the exon 20 insertion (Ex20Ins) mutation when using the cobas EGFR Mutation Test v2, may lead to inappropriate treatment

    FDA · DeviceRoche Molecular Systems, Inc.Worldwide distribution - US Nationwide distribution and the countries of…Official notice →
  6. US
    Drugs & medicalClass II

    Bio-Rad Laboratories, Inc. recalls BioPlex 2200 ANA Screen Control Set, REF: 663-1131 incompatible with ANA Screen Reagent Packs/ANA Kits, REF: 665-1150; and ANA Screen…

    A new lot of ANA screen control and any subsequent control lots are incompatible with older lot numbers of ANA calibrators and ANA reagent packs.

    FDA · DeviceBio-Rad Laboratories, Inc.Worldwide distribution - U.S Nationwide distribution including in the states…Official notice →
  7. US
    Drugs & medicalClass II

    Philips North America LLC recalls Philips, HeartStart HS1 OnSite Defibrillator, Model #'s: M5066A and M5067A

    Customers were not notified of previous recalls associated with various defibrillator models.

    FDA · DevicePhilips North America LLCU.S.: CA, CT, FL, GA, IN, MI, MO, NJ, NY, OH, TX, and WA. International…Official notice →
See all drugs & medical recalls →